Hyloris’ Dispute With AltaThera Reaches Another Milestone After Arbitration
The Panel’s Final Verdict Clears Hyloris Of Financial Liabilities
Hyloris’ dispute with AltaThera over the cardiovascular drug Sotalol IV has reached another milestone with a final verdict from an arbitration panel, which cleared Hyloris of financial liabilities while also denying its own claims.
